About SpiroChem
SpiroChem is a company based in Zurich (Switzerland) founded in 2011. SpiroChem has completed 1 acquisition, including Cyclenium Pharma. SpiroChem operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Liverpool ChiroChem, IRBM and Personal Chemistry, among others.
- Headquarter Zurich, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spirochem Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$600.76 K (USD), Grant
Apr 01, 2020
-
Investors
European Union
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of SpiroChem
Unlock access to complete
Leadership Team
3 people
Research Team
2 people
Finance and Accounting
1 people
Innovative Team
1 people
Unlock access to complete
Funding Insights of SpiroChem
Investors in SpiroChem
SpiroChem has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
University backed startup accelerator
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for SpiroChem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SpiroChem
SpiroChem has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cyclenium Pharma.
Investment portfolio details for SpiroChem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Canadian, preclinical-stage biopharma developing macrocycle drugs for oncology, infections, and pain
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for SpiroChem
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SpiroChem
Detailed financials for SpiroChem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spirochem Comparisons
Peer comparison for SpiroChem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SpiroChem
SpiroChem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Liverpool ChiroChem, IRBM and Personal Chemistry, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| Locked | Locked | Locked |
Small organic molecules are supplied for biotech and pharmaceutical R&D.
|
|
| Locked | Locked | Locked |
Integrated drug discovery and preclinical development services are provided.
|
|
| Locked | Locked | Locked |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
Detailed competitors of SpiroChem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spirochem
Complete news archive for SpiroChem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpiroChem
SpiroChem was founded in 2011.
SpiroChem is headquartered in Zurich, Switzerland.
SpiroChem was founded in 2011 in Zurich, Switzerland, as a fine chemicals company. Active pharmaceutical ingredients, intermediates, and custom synthesis services are supplied to the pharmaceutical and biotechnology sectors. Customized libraries of intermediates are developed based on client specifications. Operations focus on supporting research and development needs in these industries.
SpiroChem's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
SpiroChem has made 1 acquisition, including Cyclenium Pharma.
SpiroChem has 2 investors. Key investors include European Union, and Venture Kick.